Welcome to Our Medtech Talk Podcast Channel
Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.
In this episode of Medtech Talk, host Geoff Pardo and Per Langoe, CEO of GT Medical, discuss Langoe’s extensive career, from his start in sales to eventually making his way to medtech. Langoe gives tips on how to keep investors on board during times of crisis (such as the Covid-19 pandemic) and how he hires the right people for the job, as well as the differences between small companies and big companies and owning your company versus selling it to a larger company. He also shares what attracted him to GT Medical, what the company’s future looks like, and more. Thanks to Silicon Valley Bank for hosting this episode.
Medtech Talk boiler: The Medtech Talk Podcast explores the lives and stories of the people behind some of the greatest advancements in healthcare. Gilde Healthcare General Partner and podcast host, Geoff Pardo invites listeners to see themselves in the journeys of the greatest entrepreneurs, investors, and executives changing the landscape of medtech to save patients and innovate healthcare for future generations.
Medtech Talk Links:
Cambridge Healthtech Institute Medtech Talk Gilde Healthcare
GT Medical:
GT Medical
GammaTile:
GammaTile
Per Langoe, CEO, GT Medical With a unique blend of visionary leadership and artistic insight, Per Langoe defines success beyond cutting-edge products. It’s about fostering a culture of innovation, nurturing our people, and refining our process to break down barriers. He believes that by comprehensively assessing the landscape of life sciences, identifying the issues and roadblocks impeding patient success, and innovating solutions to surmount those barriers, we can truly make a difference.
Mr. Langoe brings more than 20 years of experience successfully managing commercial, clinical, M&A, and other functions at MedTech companies such as Parmacia Corporation, Q-Med, Galderma and Nestlé Skin Health.
Most recently, Mr. Langoe was the co-founder, President and CEO of Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes. Under Per’s leadership, the Palette team successfully designed and navigated a complex randomized controlled trial and subsequent regulatory approval process. Following product approval, the company commercialized the product to a multi-disciplinary set of clinicians, with particular emphasis on radiation oncologists, and the product’s rapid adoption led to the company’s acquisition by Teleflex in 2023
As an avid art collector, Per has seen many beautiful things, but one image stays with him. In his early days, working with an intraocular eye lens company he interviewed a patient in her mid 80s who cried tears of joy because she could now actually see her grandchildren again. Profound patient experiences like this is what propels Per’s commitment to advance the mission of improving the lives of patients with brain tumor at GT Medical Technologies.
Per received an MSc in Business Studies and Economics with a major in Business Studies, and a BSc in Business Administration and Economics with a major in International Business Studies, from Uppsala University in Sweden.
